What is the current Montelukast Sodium Preparations market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Montelukast Sodium Preparations market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Montelukast Sodium Preparations market?

Increasing asthma prevalence and rising demand for anti-asthmatic medications drive the market.

What challenges does the Montelukast Sodium Preparations market face?

Patent expirations and generic competition pose significant challenges to the market.

Which regions are the leaders in the Montelukast Sodium Preparations market?

North America and Europe are the leading regions due to high asthma prevalence.

Who are the top companies in the Montelukast Sodium Preparations market?

Merck, AstraZeneca, and GlaxoSmithKline are prominent players in the market.

What future opportunities exist in the Montelukast Sodium Preparations market?

Emerging markets and increasing demand for combination therapies offer future opportunities.

How does technology impact the Montelukast Sodium Preparations market?

Advances in drug delivery systems and personalized medicine enhance market growth.

What is the current regulatory landscape for the Montelukast Sodium Preparations market?

Stringent regulations and safety standards govern the market, ensuring product quality.

What is the future outlook for the Montelukast Sodium Preparations market?

The market is expected to experience steady growth, driven by increasing demand and innovation.

Montelukast Sodium Preparations Growth Trends & Strategic Outlook 2033

Montelukast Sodium Preparations by Application (Hospital, Clinic, Other), by Types (Chewable Tablets, Regular Tablet, Particles), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Montelukast Sodium Preparations Market Size | CAGR 2019 Forecast 2033

Montelukast Sodium Preparations Growth Trends & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Montelukast Sodium Preparations Market Overview

The Montelukast Sodium Preparations market refers to the global industry involved in the production and distribution of montelukast sodium, a medication used to treat asthma and allergic rhinitis. As a key segment of the pharmaceutical industry, the Montelukast Sodium Preparations market size is expected to experience significant growth outlook over the forecast period, driven by increasing demand for effective treatments and the expanding market forecast. The industry expansion is anticipated to be fueled by advancements in technology, changing consumer behavior, and rising competitive intensity, with the current market size estimated to be around $1.4 billion.

Loading chart…

The Montelukast Sodium Preparations market is expected to grow at a CAGR of around 5-7% from 2026 to 2033, driven by macro drivers such as increasing prevalence of asthma and allergic rhinitis, and rising healthcare expenditure. Key forces shaping the industry include technology shifts towards more efficient manufacturing processes, regulations governing the use of montelukast sodium, and consumer behavior driven by increasing awareness of health and wellness. The largest region for the Montelukast Sodium Preparations market is North America, while the fastest-growing region is expected to be Asia Pacific, driven by rising demand for pharmaceuticals and increasing investment in healthcare infrastructure.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Morepen Laboratories; Mylan; Teva Pharmaceuticals; Merck; Sandoz; Aurobindo Pharma; Otsuka Pharmaceutical; Yangtze River Pharmaceutical (Group) Co.,Ltd.; Beijing Winsunny Pharmaceutical Co.,Ltd.; Nanjing Hicin Pharmaceutical Co.,Ltd.; Zhejiang NuoDe Pharmaceutical Co.， Ltd.; Hefei Yingtai Pharmaceutical Co.,Ltd.; Lunan Better Pharmaceutical Co.,Ltd.; Qilu Pharmaceutical; CSPC Pharmaceutical Group Limited
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Montelukast Sodium Preparations market is poised for significant growth, driven by increasing demand for effective treatments of asthma and allergic rhinitis. Understanding the market dynamics is crucial for stakeholders to navigate the competitive landscape and capitalize on emerging opportunities.

Growth Drivers2 items

The rising prevalence of respiratory diseases, such as asthma, is expected to drive the Montelukast Sodium Preparations market size, with the global market projected to witness a substantial growth forecast in the coming years.

Advancements in drug delivery technologies and the development of combination therapies are further propelling the growth of the Montelukast Sodium Preparations market, as manufacturers focus on improving patient outcomes and enhancing product portfolios.

Restraints2 items

Stringent regulatory requirements and the high cost of developing and commercializing new treatments are significant restraints on the Montelukast Sodium Preparations market, as companies must navigate complex approval processes and manage investments in research and development.

The presence of generic versions of Montelukast Sodium Preparations and the availability of alternative treatments are also limiting the market growth, as patients and healthcare providers seek affordable and effective options for managing respiratory conditions.

Opportunities2 items

The increasing adoption of personalized medicine and the growing demand for targeted therapies are creating new opportunities in the Montelukast Sodium Preparations market, as companies develop innovative products and services tailored to specific patient needs.

Expanding into emerging markets and establishing partnerships with local players are also key opportunities for manufacturers to increase their presence and penetrate new regions, driving growth and revenue in the Montelukast Sodium Preparations market.

Challenges2 items

The Montelukast Sodium Preparations market is highly competitive, with numerous players competing for market share, and companies must differentiate their products and services to remain competitive and achieve a strong growth forecast.

Managing supply chain complexities and ensuring the quality of products are significant challenges in the Montelukast Sodium Preparations market, as manufacturers must balance demand and supply while maintaining high standards of production and distribution.

Market Segmentation

Loading chart…

The Application segment of the Montelukast Sodium Preparations market refers to the various uses of the medication, including the treatment of asthma and allergic rhinitis. This segment is crucial in determining the overall Montelukast Sodium Preparations market size, as it directly affects the demand for the medication. The Montelukast Sodium Preparations segmentation by application provides valuable insights into the market, enabling stakeholders to understand the potential for growth and development in specific areas.

The Types segment of the Montelukast Sodium Preparations market includes subtypes such as [object Object] and [object Object], which represent different formulations or delivery methods of the medication. This segment contributes to the overall market size by catering to diverse patient needs and preferences. Understanding the market taxonomy of Montelukast Sodium Preparations is essential for manufacturers and researchers to develop targeted strategies and products that meet the requirements of specific patient groups, ultimately driving growth in the market.

Montelukast Sodium Preparations Segmentation Breakdown8 items

Application

Hospital

Clinic

Other

Types

Chewable Tablets

Regular Tablet

Particles

Regional Insights

Loading chart…

The Montelukast Sodium Preparations market growth is anticipated to be driven by various regional factors. North America, with a significant adoption of Montelukast Sodium Preparations, is expected to be the largest region, driven by factors such as favorable policies, high investments in healthcare infrastructure, and a mature ecosystem. The region's large patient population and high demographics also contribute to its dominance.

Asia Pacific is projected to be the fastest-growing region, driven by increasing infrastructure development, rising demographics, and growing adoption of Montelukast Sodium Preparations. Europe, with its established healthcare system, is also expected to contribute significantly to the Montelukast Sodium Preparations market growth. Latin America and Middle East & Africa, although smaller markets, are expected to experience growth due to improving ecosystem maturity and increasing investments in healthcare.

Key Regional Drivers5 items

North America: favorable policies, high investments, and mature ecosystem

Asia Pacific: increasing infrastructure development, rising demographics, and growing adoption

Europe: established healthcare system and high adoption rates

Latin America: improving ecosystem maturity and increasing investments

Middle East & Africa: growing adoption and investments in healthcare infrastructure

Competitive Landscape

The Montelukast Sodium Preparations market is moderately consolidated, with a mix of global players and local/regional companies. The market is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Understanding the Montelukast Sodium Preparations competitive landscape is crucial for companies to develop effective strategies. Global players focus on product innovation and regulatory approvals, while local companies emphasize pricing and distribution.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. They also focus on technology, service model, channel strength, customization, and cost advantages to stay competitive. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players adapt their strategies to address these challenges and maintain their market position.

Morepen Laboratories: regional expansion

Mylan: vertical integration

Teva Pharmaceuticals: premium pricing

Merck: OEM tie-ups

Sandoz: innovation pipeline

Aurobindo Pharma: local manufacturing

Key Montelukast Sodium Preparations Companies15 items

Morepen Laboratories

Mylan

Teva Pharmaceuticals

Merck

Sandoz

Aurobindo Pharma

Otsuka Pharmaceutical

Yangtze River Pharmaceutical (Group) Co.,Ltd.

Beijing Winsunny Pharmaceutical Co.,Ltd.

Nanjing Hicin Pharmaceutical Co.,Ltd.

Zhejiang NuoDe Pharmaceutical Co.， Ltd.

Hefei Yingtai Pharmaceutical Co.,Ltd.

Lunan Better Pharmaceutical Co.,Ltd.

Qilu Pharmaceutical

CSPC Pharmaceutical Group Limited

Market Ecosystem

The Montelukast Sodium Preparations ecosystem encompasses a network of participants that contribute to the creation and delivery of these preparations. The ecosystem can be broadly categorized into upstream, midstream, and downstream segments, with technology providers and suppliers at the upstream end, integrators and manufacturers in the midstream, and channels and end users at the downstream end. As value flows through the ecosystem, it is created and captured at various points, from the sourcing of raw materials to the final delivery of preparations to end users.

Raw material suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce Montelukast Sodium Preparations

Distributors / channel partners — manage logistics and distribution

Regulators/standards bodies — oversee quality and safety standards

Service providers / after-sales — offer support and maintenance services

End users / buyers — purchase and administer preparations

Data/analytics providers — provide insights on market trends and user behavior

In the Montelukast Sodium Preparations ecosystem, control points are primarily held by regulators and manufacturers, who influence adoption through standards and approvals. Dependency risks arise from input constraints, such as the availability of active pharmaceutical ingredients, and from regulatory approvals. Switching costs are relatively high due to the specialized nature of the preparations, and partnerships between manufacturers and distributors are critical for ensuring timely delivery. As the ecosystem differs by region, with varying regulatory requirements and market conditions, a thorough value chain analysis is necessary to navigate these complexities and identify opportunities for growth and improvement.

Recent Industry Insights

The Montelukast Sodium Preparations industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed between key players to enhance research and development capabilities, driving innovation in the sector. Furthermore, there have been strategic mergers and acquisitions aimed at expanding product portfolios and strengthening market presence. Recent product launches have also focused on improving efficacy and safety profiles of Montelukast Sodium Preparations, catering to the evolving needs of patients and healthcare providers. Regulatory changes have emphasized the importance of quality control and adherence to stringent manufacturing standards, influencing the overall landscape of the industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Montelukast Sodium Preparations market outlook. The market exhibits moderate attractiveness due to its established presence and stable demand. However, the competitive intensity is relatively high, driven by the presence of numerous generic manufacturers. The long-term outlook appears promising, with opportunities for innovation in sustained-release formulations and combination therapies. The demand-supply balance is expected to remain neutral, with no significant disruptions anticipated. Key risk factors include regulatory changes and fluctuations in raw material prices. Overall, the Montelukast Sodium Preparations market is poised for steady growth, driven by its essential role in managing asthma and allergic rhinitis.

12 items

1. Executive Summary

2. Montelukast Sodium Preparations Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Montelukast Sodium Preparations Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Montelukast Sodium Preparations Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Montelukast Sodium Preparations Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Montelukast Sodium Preparations Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Montelukast Sodium Preparations Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Montelukast Sodium Preparations Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Montelukast Sodium Preparations Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Montelukast Sodium Preparations Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Montelukast Sodium Preparations Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Montelukast Sodium Preparations Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Montelukast Sodium Preparations Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Montelukast Sodium Preparations Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Montelukast Sodium Preparations Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Montelukast Sodium Preparations Market Competition by Key Manufacturers

9.1. Global Montelukast Sodium Preparations Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Montelukast Sodium Preparations: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Morepen Laboratories

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Mylan

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Teva Pharmaceuticals

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Merck

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Sandoz

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Aurobindo Pharma

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Otsuka Pharmaceutical

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Yangtze River Pharmaceutical (Group) Co.,Ltd.

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Beijing Winsunny Pharmaceutical Co.,Ltd.

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Nanjing Hicin Pharmaceutical Co.,Ltd.

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Zhejiang NuoDe Pharmaceutical Co.， Ltd.

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Hefei Yingtai Pharmaceutical Co.,Ltd.

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Lunan Better Pharmaceutical Co.,Ltd.

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Qilu Pharmaceutical

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. CSPC Pharmaceutical Group Limited

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Montelukast Sodium Preparations Market

Figure 4: Global Montelukast Sodium Preparations Market: Drivers

Figure 5: Global Montelukast Sodium Preparations Market: Challenges

Figure 6: Global Montelukast Sodium Preparations Market: Trends

Figure 7: Global Montelukast Sodium Preparations Market: Opportunity

Figure 8: Global Montelukast Sodium Preparations Market: Restraint

Figure 9: Global Montelukast Sodium Preparations Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Montelukast Sodium Preparations Market Value (USD Million) By Region

Figure 19: Global Montelukast Sodium Preparations Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Montelukast Sodium Preparations Market Value (USD Million) By Region

Figure 27: Global Montelukast Sodium Preparations Market Share (%) By: Regions (2032)

Figure 28: Global Montelukast Sodium Preparations Market Volume (K) By Region

Figure 29: Global Montelukast Sodium Preparations Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Montelukast Sodium Preparations Market Value (USD Million) By Region

Figure 37: Global Montelukast Sodium Preparations Market Share (%) By: Regions (2032)

Figure 38: Global Montelukast Sodium Preparations Market Volume (K) By Region

Figure 39: Global Montelukast Sodium Preparations Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

125 items

Table 1: Market Segmentation Analysis

Table 2: Global Montelukast Sodium Preparations Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Montelukast Sodium Preparations Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Montelukast Sodium Preparations Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Montelukast Sodium Preparations Market Value (USD Million) By Region

Table 14: Global Montelukast Sodium Preparations Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Montelukast Sodium Preparations Market Volume (K) By Region

Table 31: Global Montelukast Sodium Preparations Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Montelukast Sodium Preparations Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Montelukast Sodium Preparations Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Montelukast Sodium Preparations Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Morepen Laboratories Basic Information And Sales Area

Table 52: Morepen Laboratories. Products Portfolio

Table 53: Mylan Basic Information And Sales Area

Table 54: Mylan. Products Portfolio

Table 55: Teva Pharmaceuticals Basic Information And Sales Area

Table 56: Teva Pharmaceuticals. Products Portfolio

Table 57: Merck Basic Information And Sales Area

Table 58: Merck. Products Portfolio

Table 59: Sandoz Basic Information And Sales Area

Table 60: Sandoz. Products Portfolio

Table 61: Aurobindo Pharma Basic Information And Sales Area

Table 62: Aurobindo Pharma. Products Portfolio

Table 63: Otsuka Pharmaceutical Basic Information And Sales Area

Table 64: Otsuka Pharmaceutical. Products Portfolio

Table 65: Yangtze River Pharmaceutical (Group) Co.,Ltd. Basic Information And Sales Area

Table 66: Yangtze River Pharmaceutical (Group) Co.,Ltd.. Products Portfolio

Table 67: Beijing Winsunny Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 68: Beijing Winsunny Pharmaceutical Co.,Ltd.. Products Portfolio

Table 69: Nanjing Hicin Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 70: Nanjing Hicin Pharmaceutical Co.,Ltd.. Products Portfolio

Table 71: Zhejiang NuoDe Pharmaceutical Co.， Ltd. Basic Information And Sales Area

Table 72: Zhejiang NuoDe Pharmaceutical Co.， Ltd.. Products Portfolio

Table 73: Hefei Yingtai Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 74: Hefei Yingtai Pharmaceutical Co.,Ltd.. Products Portfolio

Table 75: Lunan Better Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 76: Lunan Better Pharmaceutical Co.,Ltd.. Products Portfolio

Table 77: Qilu Pharmaceutical Basic Information And Sales Area

Table 78: Qilu Pharmaceutical. Products Portfolio

Table 79: CSPC Pharmaceutical Group Limited Basic Information And Sales Area

Table 80: CSPC Pharmaceutical Group Limited. Products Portfolio

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Value (USD Million) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Volume (K) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global Montelukast Sodium Preparations Market Value (USD Million) By Region

Table 90: Global Montelukast Sodium Preparations Market Share (%) By Region (2025-2032)

Table 91: North America Market Value (USD Million) (2025-2032) By Country

Table 92: North America Market Value (USD Million) (2025-2032) By Application

Table 93: North America Market Value (USD Million) (2025-2032) By Types

Table 94: Europe Market Value (USD Million) (2025-2032) By Country

Table 95: Europe Market Value (USD Million) (2025-2032) By Application

Table 96: Europe Market Value (USD Million) (2025-2032) By Types

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 100: South America Market Value (USD Million) (2025-2032) By Country

Table 101: South America Market Value (USD Million) (2025-2032) By Application

Table 102: South America Market Value (USD Million) (2025-2032) By Types

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 106: Global Montelukast Sodium Preparations Market Volume (K) By Region

Table 107: Global Montelukast Sodium Preparations Market Share (%) By Region (2025-2032)

Table 108: North America Market Volume (K) (2025-2032) By Country

Table 109: North America Market Volume (K) (2025-2032) By Application

Table 110: North America Market Volume (K) (2025-2032) By Types

Table 111: Europe Market Volume (K) (2025-2032) By Country

Table 112: Europe Market Volume (K) (2025-2032) By Application

Table 113: Europe Market Volume (K) (2025-2032) By Types

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 115: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 117: South America Market Volume (K) (2025-2032) By Country

Table 118: South America Market Volume (K) (2025-2032) By Application

Table 119: South America Market Volume (K) (2025-2032) By Types

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 121: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 123: Research Programs/Design For This Report

Table 124: Key Data Information From Secondary Sources

Table 125: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Montelukast Sodium Preparations Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Morepen Laboratories; Mylan; Teva Pharmaceuticals; Merck; Sandoz; Aurobindo Pharma; Otsuka Pharmaceutical; Yangtze River Pharmaceutical (Group) Co.,Ltd.; Beijing Winsunny Pharmaceutical Co.,Ltd.; Nanjing Hicin Pharmaceutical Co.,Ltd.; Zhejiang NuoDe Pharmaceutical Co.， Ltd.; Hefei Yingtai Pharmaceutical Co.,Ltd.; Lunan Better Pharmaceutical Co.,Ltd.; Qilu Pharmaceutical; CSPC Pharmaceutical Group Limited
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options